Getty Copper closes flow-through private placement raising C$15M

Getty Copper Inc. (TSXV: GTC) (OTCQX: GTCDF) has closed a flow-through share private placement, raising aggregate gross proceeds of C$15,023,478.78, according to a press release dated October 8, 2026.

The offering consisted of a brokered portion and a concurrent non-brokered portion. Under the brokered offering, the company issued 7,352,566 BC flow-through shares at C$1.395 each and 2,117,434 charity flow-through shares at C$1.305 each, generating gross proceeds of C$13,020,080.94. Velocity Capital Partners, Clarus Securities Inc., and Raymond James Ltd. acted as agents, receiving a 6% cash commission on gross proceeds and 568,200 compensation warrants exercisable at C$0.97 per share for 16 months following closing.

The non-brokered portion involved the issuance of 1,854,998 flow-through shares at C$1.080 each, raising C$2,003,397.84, with no commission payable.

Insiders participated in the non-brokered offering, subscribing for 483,000 flow-through shares for aggregate proceeds of C$521,640. The company relied on exemptions from formal valuation and minority shareholder approval requirements under Multilateral Instrument 61-101, as insider participation did not exceed 25% of the company's market capitalization.

Getty Copper also engaged Velocity Capital Partners and Clarus Securities Inc. for strategic advisory services, paying a flat fee of C$105,000 plus applicable taxes and issuing 110,000 advisory warrants exercisable at C$0.97 per share for 16 months.

Proceeds will be used to incur eligible Canadian exploration expenses qualifying as flow-through critical mineral mining expenditures related to the company's British Columbia projects, on or before December 31, 2027. Qualifying expenditures are to be renounced in favor of initial subscribers with an effective date no later than December 31, 2026.

The offering was made under the listed issuer financing exemption, meaning the shares bear no hold period under Canadian securities laws. The TSX Venture Exchange provided conditional approval on September 18, 2026, with final acceptance still pending.

You May Also Be Interested In

• Humana soars, Alignment Healthcare sinks on Medicare rating changes
• International Paper assigns committee roles to two new board members
• After-Hours Movers: T, VZ, TMUS, SPCX, HUM, ALHC, CVS, CLOV, UNH, AXP